UBS Group
KEQU icon

UBS Group’s Kewaunee Scientific KEQU Stock Holding History

UBS Group’s Portfolio KEQU Stock Details KEQU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11K Buy
309
+222
+255% +$8.24K ﹤0.01% 8522
2026
Q1 		$2.98K Buy
87
+84
+2,800% +$3.25K ﹤0.01% 9166
2025
Q4 		$112 Sell
3
-512
-99% -$20.8K ﹤0.01% 10172
2025
Q3 		$22K Buy
+515
New +$27.7K ﹤0.01% 8090
2025
Q2 		– Sell
-4,087
Closed -$161K – 10571
2025
Q1 		$161K Buy
4,087
+670
+20% +$37.5K ﹤0.01% 6700
2024
Q4 		$211K Sell
3,417
-2,988
-47% -$122K ﹤0.01% 6415
2024
Q3 		$213K Buy
6,405
+5,520
+624% +$259K ﹤0.01% 5827
2024
Q2 		$41.8K Buy
+885
New +$33.5K ﹤0.01% 6832
2023
Q2 		– Sell
-70
Closed -$1.08K – 9286
2023
Q1 		$1.08K Buy
+70
New +$1.11K ﹤0.01% 8819
2022
Q3 		– Sell
-336
Closed -$6K – 10639
2022
Q2 		$6K Sell
336
-831
-71% -$11.9K ﹤0.01% 8685
2022
Q1 		$17K Sell
1,167
-501
-30% -$7.05K ﹤0.01% 7656
2021
Q4 		$21K Buy
1,668
+361
+28% +$4.61K ﹤0.01% 7784
2021
Q3 		$17K Buy
1,307
+958
+274% +$12.9K ﹤0.01% 7338
2021
Q2 		$5K Sell
349
-1,459
-81% -$18K ﹤0.01% 8551
2021
Q1 		$22K Buy
+1,808
New +$22.6K ﹤0.01% 7291
2020
Q4 		– Sell
-266
Closed -$2K – 8568
2020
Q3 		$2K Sell
266
-1,379
-84% -$13.1K ﹤0.01% 7665
2020
Q2 		$15K Sell
1,645
-1,439
-47% -$13.3K ﹤0.01% 6737
2020
Q1 		$25K Buy
3,084
+234
+8% +$2.59K ﹤0.01% 6347
2019
Q4 		$38K Buy
2,850
+222
+8% +$3.47K ﹤0.01% 6514
2019
Q3 		$41K Sell
2,628
-1,224
-32% -$20.6K ﹤0.01% 6308
2019
Q2 		$73K Sell
3,852
-281
-7% -$6.03K ﹤0.01% 5611
2019
Q1 		$87K Sell
4,133
-216
-5% -$6.14K ﹤0.01% 5169
2018
Q4 		$145K Buy
4,349
+561
+15% +$15.3K ﹤0.01% 5210
2018
Q3 		$120K Buy
3,788
+31
+0.8% +$1.03K ﹤0.01% 5435
2018
Q2 		$135K Buy
3,757
+757
+25% +$25.6K ﹤0.01% 5231
2018
Q1 		$102K Sell
3,000
-219
-7% -$6.42K ﹤0.01% 5208
2017
Q4 		$93K Sell
3,219
-281
-8% -$8.09K ﹤0.01% 5404
2017
Q3 		$103K Hold
3,500
– – ﹤0.01% 5300
2017
Q2 		$87K Sell
3,500
-147
-4% -$3.4K ﹤0.01% 5260
2017
Q1 		$84K Buy
3,647
+147
+4% +$3.56K ﹤0.01% 5175
2016
Q4 		$86K Hold
3,500
– – ﹤0.01% 5396
2016
Q3 		$83K Sell
3,500
-2,530
-42% -$55.8K ﹤0.01% 5107
2016
Q2 		$114K Hold
6,030
– – ﹤0.01% 4939
2016
Q1 		$100K Sell
6,030
-1,358
-18% -$22.8K ﹤0.01% 4981
2015
Q4 		$131K Sell
7,388
-1,121
-13% -$19K ﹤0.01% 5005
2015
Q3 		$140K Buy
8,509
+2,479
+41% +$41.7K ﹤0.01% 4938
2015
Q2 		$102K Hold
6,030
– – ﹤0.01% 5388
2015
Q1 		$106K Sell
6,030
-665
-10% -$11.7K ﹤0.01% 5358
2014
Q4 		$119K Buy
+6,695
New +$118K ﹤0.01% 5520

Other funds holding KEQU

Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $158M AUM 42.05% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
DLP
De Lisle Partners Poole, United Kingdom $916M AUM 54.05% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NIM
Northeast Investment Management Boston, Massachusetts $2.71B AUM 25.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group's KEQU Position: Q2 2026 in Review

UBS Group increased its Kewaunee Scientific (KEQU) stake by 255% in Q2 2026, buying an estimated $8.24K and bringing the position to 309 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #8522.

UBS Group first reported a position in KEQU in Q4 2014 and has held it in 39 quarters since. The position peaked at $213K in Q3 2024. 22 funds tracked by Wall St. Rank hold KEQU as of Q2 2026.

  • UBS Group held 309 shares of Kewaunee Scientific worth $11K as of Q2 2026.
  • UBS Group bought 222 Kewaunee Scientific shares in Q2 2026, an estimated $8.24K.
  • Kewaunee Scientific made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #8522 holding.
  • UBS Group first reported a position in Kewaunee Scientific in Q4 2014 and has held it in 39 quarters since.
  • UBS Group's Kewaunee Scientific position peaked at $213K in Q3 2024.
  • 22 funds tracked by Wall St. Rank held Kewaunee Scientific as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.